105 related articles for article (PubMed ID: 6825804)
1. Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan.
Leibovici J
Experientia; 1983 Mar; 39(3):326-7. PubMed ID: 6825804
[TBL] [Abstract][Full Text] [Related]
2. Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.
Leibovici J
Cancer Res; 1984 May; 44(5):1981-4. PubMed ID: 6713396
[TBL] [Abstract][Full Text] [Related]
3. Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers.
Leibovici J; Hoenig S; Stark Y; Kopel S; Wolman M
Exp Cell Biol; 1984; 52(4):219-24. PubMed ID: 6734889
[TBL] [Abstract][Full Text] [Related]
4. Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma.
Sinai Y; Leibovici J; Wolman M
Cancer Res; 1976 May; 36(5):1593-7. PubMed ID: 1268821
[TBL] [Abstract][Full Text] [Related]
5. Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide.
Michowitz M; Stark Y; Leibovici J
Cancer Lett; 1984 Jul; 23(3):343-9. PubMed ID: 6744256
[TBL] [Abstract][Full Text] [Related]
6. Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice.
Leibovici J; Sinai Y; Wolman M; Davidai G
Cancer Res; 1975 Aug; 35(8):1921-5. PubMed ID: 1149016
[TBL] [Abstract][Full Text] [Related]
7. The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.
Leibovici J; Borit A; Sandbank U; Wolman M
Br J Cancer; 1979 Oct; 40(4):597-607. PubMed ID: 497110
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of Lewis lung carcinoma by tumor excision and levan.
Leibovici J; Michowitz M; Shezen E; Wolman M; Sandbank U
Oncology; 1981; 38(1):31-4. PubMed ID: 7443174
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
Leibovici J; Stark Y; Wolman M
Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
[TBL] [Abstract][Full Text] [Related]
10. Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent.
Michowitz M; Kopel S; Hoenig S; Leibovici J
J Surg Oncol; 1987 Apr; 34(4):268-71. PubMed ID: 3560964
[TBL] [Abstract][Full Text] [Related]
11. Slow cytotoxicity of the polysaccharide levan on tumor cells in vitro.
Leibovici J; Stark Y
Chem Biol Interact; 1986 Nov; 60(2):191-200. PubMed ID: 3791487
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the inhibitory effect of levan on experimental tumors.
Leibovici J; Stark Y; Eldar T; Brudner G; Wolman M
Recent Results Cancer Res; 1980; 75():173-9. PubMed ID: 7232830
[TBL] [Abstract][Full Text] [Related]
13. The tissue reaction to implanted foreign bodies in levan-treated mice.
Papadimitriou JM; Robertson TA; Wolman M; Walters MN
Pathology; 1978 Jul; 10(3):235-41. PubMed ID: 364388
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic activity of levan polysaccharide in alloxan-induced diabetic rats.
Dahech I; Belghith KS; Hamden K; Feki A; Belghith H; Mejdoub H
Int J Biol Macromol; 2011 Nov; 49(4):742-6. PubMed ID: 21782842
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the central nervous system in malignant lymphomas of mice.
Kupper H; Gerlach H; Wessel H; Kleemann D; Schmerling S
Exp Pathol; 1987; 31(3):185-9. PubMed ID: 3609242
[TBL] [Abstract][Full Text] [Related]
16. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
Leibovici J; Kopel S; Wolman M
Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
[TBL] [Abstract][Full Text] [Related]
17. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
Stark Y; Leibovici J
Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
[TBL] [Abstract][Full Text] [Related]
18. The effects of levan on the acute inflammatory response.
Sedgwick AD; Rutman A; Sin YM; Mackay AR; Willoughby DA
Br J Exp Pathol; 1984 Apr; 65(2):215-22. PubMed ID: 6201184
[TBL] [Abstract][Full Text] [Related]
19. AKR lymphoma malignancy variants differing at late phase of metastasis.
Michowitz M; Klein O; Sharabi Y; Siegal A; Leibovici J
Cancer Lett; 1990 Jun; 52(1):39-47. PubMed ID: 2354418
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
Rosner A; Peled A; Haran-Ghera N; Canaani E
Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
